Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Depomed has appointed James Schoeneck as the new president and CEO, effective 18 April 2011.
Subscribe to our email newsletter
Prior to joining Depomed, Schoeneck worked as the CEO of BrainCells, a biopharmaceutical company in San Diego, California.
Before BrainCells, Schoeneck was the president and CEO of a specialty pharmaceutical company, Prometheus Laboratories.
Depomed board of directors chairman Peter Staple said Schoeneck has a great track record of commercial and operational achievements and developing successful business strategies.